Skip to the page

Data / Form D filings / Aer Therapeutics, Inc.

Aer Therapeutics, Inc.: Form D filings

Aer Therapeutics, Inc., a biotechnology company in Research Triangle Park, NC, filed 3 Form D notices with the SEC between 2022 and 2026. The latest, on August 19, 2026, reports $3 million sold of a $3 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8 Davis Dr, Research Triangle Park, NC, 27709
Phone
(213) 247-8328
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1959576

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 19, 2026New notice$3,000,000$3,000,0007Aug 7, 2026sec.gov
Feb 7, 2025New notice$5,000,000$5,000,00015Jan 24, 2025sec.gov
Dec 22, 2022New notice$36,882,384$15,882,384$21,000,00023Dec 9, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thomas MathersExecutive Officer, Director
John FahyDirector
Evan CaplanDirector
Tim ShannonDirector
Christy ShafferDirector

Other biotechnology companies in North Carolina that filed recently

Every Form D from the week of Aug 17, 2026 · All recent filings in North Carolina · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Aer Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.